Abbott Laboratories (LON:0Q15)
London
· Delayed Price · Currency is GBP · Price in USD 131.32
+0.28 (0.21%)
At close: Mar 28, 2025
Abbott Laboratories Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 27, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 176,692 | 156,706 | 150,019 | 158,875 | 178,253 | 137,406 | Upgrade
|
| Market Cap Growth | 4.46% | 4.46% | -5.57% | -10.87% | 29.73% | 18.47% | Upgrade
|
| Enterprise Value | 182,528 | 162,689 | 156,979 | 164,587 | 184,841 | 147,690 | Upgrade
|
| Last Close Price | 101.72 | 89.55 | 84.25 | 86.63 | 98.38 | 73.86 | Upgrade
|
| PE Ratio | 16.57 | 14.69 | 33.52 | 27.72 | 34.28 | 41.94 | Upgrade
|
| PS Ratio | 4.68 | 4.68 | 4.76 | 4.39 | 5.60 | 5.42 | Upgrade
|
| PB Ratio | 4.10 | 4.10 | 4.92 | 5.19 | 6.70 | 5.68 | Upgrade
|
| P/TBV Ratio | 10.96 | 10.96 | 31.28 | 55.76 | - | - | Upgrade
|
| P/FCF Ratio | 30.89 | 30.89 | 37.77 | 24.53 | 27.91 | 32.77 | Upgrade
|
| P/OCF Ratio | 22.92 | 22.92 | 26.32 | 19.98 | 22.92 | 23.74 | Upgrade
|
| EV/Sales Ratio | 5.62 | 4.86 | 4.99 | 4.54 | 5.81 | 5.83 | Upgrade
|
| EV/EBITDA Ratio | 21.29 | 19.01 | 19.11 | 16.02 | 19.64 | 22.94 | Upgrade
|
| EV/EBIT Ratio | 31.48 | 27.17 | 27.69 | 21.76 | 27.19 | 36.92 | Upgrade
|
| EV/FCF Ratio | 35.98 | 32.07 | 39.52 | 25.41 | 28.94 | 35.23 | Upgrade
|
| Debt / Equity Ratio | 0.32 | 0.32 | 0.41 | 0.49 | 0.53 | 0.60 | Upgrade
|
| Debt / EBITDA Ratio | 1.38 | 1.38 | 1.47 | 1.41 | 1.47 | 2.18 | Upgrade
|
| Debt / FCF Ratio | 2.40 | 2.40 | 3.14 | 2.30 | 2.23 | 3.48 | Upgrade
|
| Asset Turnover | 0.54 | 0.54 | 0.54 | 0.58 | 0.58 | 0.49 | Upgrade
|
| Inventory Turnover | 2.92 | 2.92 | 2.81 | 3.37 | 3.56 | 3.22 | Upgrade
|
| Quick Ratio | 1.05 | 1.05 | 1.00 | 1.06 | 1.28 | 1.14 | Upgrade
|
| Current Ratio | 1.67 | 1.67 | 1.64 | 1.63 | 1.85 | 1.72 | Upgrade
|
| Return on Equity (ROE) | 30.91% | 30.91% | 15.11% | 19.01% | 20.49% | 13.91% | Upgrade
|
| Return on Assets (ROA) | 6.06% | 6.06% | 6.11% | 7.61% | 7.79% | 4.86% | Upgrade
|
| Return on Capital (ROIC) | 7.95% | 7.95% | 8.24% | 10.34% | 10.64% | 6.61% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.10% | 11.10% | 12.20% | 15.50% | 14.80% | 9.00% | Upgrade
|
| Earnings Yield | 6.04% | 6.83% | 3.00% | 3.62% | 2.93% | 2.40% | Upgrade
|
| FCF Yield | 2.87% | 3.24% | 2.65% | 4.08% | 3.58% | 3.05% | Upgrade
|
| Dividend Yield | 1.35% | 2.00% | 1.94% | 1.84% | 1.37% | 1.52% | Upgrade
|
| Payout Ratio | 28.62% | 28.62% | 62.13% | 47.73% | 45.28% | 56.95% | Upgrade
|
| Buyback Yield / Dilution | 0.06% | 0.06% | 0.85% | 1.40% | -0.17% | -0.28% | Upgrade
|
| Total Shareholder Return | 1.40% | 2.05% | 2.79% | 3.24% | 1.20% | 1.24% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.